Ausgabe 3/2018
Inhalt (25 Artikel)
microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3
Ji-zheng Qin, Shao-jie Wang, Chun Xia
Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events
Romain Chopard, Guillaume Serzian, Sébastien Humbert, Nicolas Falvo, Mathilde Morel-Aleton, Benjamin Bonnet, Gabriel Napporn, Elsa Kalbacher, Laurent Obert, Bruno Degano, Gilles Cappelier, Yves Cottin, François Schiele, Nicolas Meneveau
Introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified Rankin Scale score > 2
Manuel Cappellari, Gianni Turcato, Stefano Forlivesi, Nicola Micheletti, Giampaolo Tomelleri, Bruno Bonetti, Giovanni Merlino, Roberto Eleopra, Monia Russo, Roberto L’Erario, Alessandro Adami, Carolina Gentile, Anna Gaudenzi, Sandro Bruno, Paolo Bovi
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials
Babikir Kheiri, Mohammed Osman, Ahmed Abdalla, Tarek Haykal, Mahmoud Barbarawi, Yazan Zayed, Michael Hicks, Sahar Ahmed, Ghassan Bachuwa, Mustafa Hassan, Deepak L. Bhatt
The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis
Amihai Rottenstreich, Geffen Kleinstern, Hagai Amsalem, Yosef Kalish
Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada
Sarah R. Monagle, Jack Hirsh, Vinai C. Bhagirath, Jeffrey S. Ginsberg, Jackie Bosch, Paul Kruger, John W. Eikelboom
Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “Real-World” Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials
Andrew B. Hughey, Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Steve Almany, Jay Kozlowski, Dennis Besley, Gregory D. Krol, Syed Ahsan, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort
Covadonga Gómez-Cuervo, Carmen Díaz-Pedroche, María Asunción Pérez-Jacoiste Asín, Antonio Lalueza, Roberto del Pozo, Raquel Díaz-Simón, Francisco Trapiello, Diana Paredes, Carlos Lumbreras
Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis
Eiman Ghaffarpasand, Maneli D. Tehrani, Jolanta Marszalek, Gerald Chi
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
Craig I. Coleman, Alexander G. G. Turpie, Thomas J. Bunz, Jan Beyer-Westendorf
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention
Gerald Chi, Megan K. Yee, Arzu Kalayci, Mathieu Kerneis, Fahad AlKhalfan, Roxana Mehran, Christoph Bode, Jonathan L. Halperin, Freek W. A. Verheugt, Peter Wildgoose, Martin van Eickels, Gregory Y. H. Lip, Marc Cohen, Eric D. Peterson, Keith A. A. Fox, C. Michael Gibson
The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction
Guy Witberg, Jalal Bathish, Tamir Bental, Dorit Leshem-Lev, Abid Assali, Ran Kornowski, Eli Lev
Effects of cupric chloride on coagulation in human plasma: role of fibrinogen
Vance G. Nielsen, Timothy D. Ward, Paul M. Ford
The efficacy and safety of Batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis
Jiayue Ding, Da Zhou, Yanyu Hu, Omar Elmadhoun, Liqun Pan, Jingyuan Ya, Tingting Geng, Zhongao Wang, Yuchuan Ding, Xunming Ji, Ran Meng
Elevated extracellular trap formation and contact system activation in acute leukemia
Tae Yeul Kim, Ja-Yoon Gu, Hye Soo Jung, Youngil Koh, Inho Kim, Hyun Kyung Kim
Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen
Kay T. Htun, Mabel J. Y. Ma, Agnes Y. Y. Lee
First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation
Juraj Sokol, Frantisek Nehaj, Jela Ivankova, Michal Mokan, Marian Mokan
How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
Ahmet Guner, Macit Kalcik, Mustafa Ozan Gursoy, Sabahattin Gunduz, Mehmet Ozkan
Comment on “Do hospital doctors test for thrombophilia in patients with venous thromboembolism?”
Turgay Ulas
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer
F. Dentali, S. Barco, S. Pegoraro, M. N. D. Di Minno, D. Mastroiacovo, F. Pomero, C. Lodigiani, F. Bagna, M. Sartori, G. Barillari, N. Mumoli, M. Napolitano, S. M. Passamonti, R. Benedetti, W. Ageno, M. Di Nisio
Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions
Meiling Luo, Aiqiu Wei, Liqun Xiang, Jie Yan, Lin Liao, Xuelian Deng, Donghong Deng, Peng Cheng, Faquan Lin
Predictors of coronary stent thrombosis: a case–control study
José Sérgio Nascimento Silva, Isly Maria Lucena de Barros, Fabiano Lima Cantarelli, Rodrigo Cantarelli Alves, Felipe José de Andrade Falcão, Josefa Martinelly dos Santos Silva, Flávio Roberto Azevedo de Oliveira, Rodrigo Pinto Pedrosa
Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study
Stefano Forlivesi, Bruno Bonetti, Manuel Cappellari